Skip to main content

Peer Review reports

From: Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study

Original Submission
4 Feb 2021 Submitted Original manuscript
17 May 2021 Reviewed Reviewer Report - Alexander Gough
2 Aug 2021 Reviewed Reviewer Report - Munyaradzi Dimairo
4 Sep 2021 Author responded Author comments - Lara van der Schoot
Resubmission - Version 2
4 Sep 2021 Submitted Manuscript version 2
16 Sep 2021 Reviewed Reviewer Report - Alexander Gough
3 Oct 2021 Reviewed Reviewer Report - Munyaradzi Dimairo
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
4 Oct 2021 Editorially accepted
16 Oct 2021 Article published 10.1186/s13063-021-05681-z

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215